Digipharm

Healthcare worldwide does not have the relevant infrastructure to track and implement innovative model prices, they are largely reluctant to take innovative policies. Their systems are most often needed to make tough decisions on whether to provide patients with access to expensive pharmacological treatments while paying attention to their limited resources. The reason why they should absorb innovative pricing methods, is that they can overcome the challenges they face when trying to access funding for new drugs. This will allow the implementation of flexible pricing options to access maintenance prices in relation to the benefits it offers.
Some of the reasons why not many adoptions of flexible pricing solutions include:

•  Inadequate patient compliance in real time
•  Patient privacy
•  A fragmented health care system
•  The inability to use one size fits all customized platforms that can traverse all areas
•  Inconsistencies in healthcare provider services.

These problems posed a threat to the possibility of patients not receiving care that could save their lives.
The solution that Digipharm proposes is a new method for innovative crowdfunding medical services on a platform called Evolve. They will enable this funding through initial coin offerings and digital assets to support pre-clinical studies, research, ex-vivo research and preliminary evidence research evidence.
Blockchain is largely recognized as the backbone of the digital currency platform such as the Bitcoin and Ethereum networks. This is a distributed database technology. In digipharm health economics, the characteristics of blockchain technology are used as follows:

• Smart contracts - these are code snippets that execute themselves and facilitate, enforce or verify pre-defined terms / conditions of agreement.
• Private Channels - a secure channel on a DPH private blockchain will be used to transmit sensitive data and comply with all protection and regulatory laws.
• Digital Identity Service - this will be used to create profiles for registered stakeholders and patients and still maintain their anonymity on each platform.

DIGIPHARM VISION: Digipharm has a unique vision to be a pioneer in delivering sustainable and value-based healthcare, the generation of innovative evidence and patient empowerment in the health care industry.

PLATFORM DIGIPHARM
Digipharm has a platform that is a decentralized public / private blocking solution that enables the delivery of value-based pricing agreements to stakeholders. It also collects and stores tangible evidence of patient data. The Digipharm platform also enables the delivery of personalized healthcare solutions.

PLATFORM FEATURES
DIGIPHARM The digipharm platform is a unique platform and has the following features namely; integration into existing IT stakeholder infrastructure, patient websites and applications, legal / regulatory / compliance mechanisms, smart contracts for innovative pricing agreements and task automation and interfaces for manufacturers / payers / providers.

CHARACTERISTIC OF DPH TOKEN

• DPH Supply: 100,000,000 Fixed (ERC-20)
• Code Ticker: DPH
• Decimal Place: 18
• Token Price 1.00 USD

DPH TOKEN SALE
PRE - SALE: 15,000,000 DPH
Base Price: 1.0 USD
Pre-Sales Length: 4 Weeks
Pre-Discount Sales: 35%

KEY SALES: 50,000,000 DPH
Week 1: 25% is limited to 25 million tokens
Week 2: 15% closed at 15 million tokens
Week 3: 10% is limited to 10 million tokens
Week 4: 1.00 USD
Any unsold token will be burned.

DISTRIBUTION TOKEN

Reference / Bounties - 1%
Reservation / Bounties - 14%
Team / Partner - 20%
ICO - 65%

PAYMENT FUNDING

Charitable Foundation - 0.5%
Marketing - 4%
Laws & Regulations - 15%
Professional Services - 15.5%
Product Development - 65%

DIGIPHARM TEAM

• Ahmed Abdulla - Founder / CEO
• Girisha Fernando - Co-Founder / COO
• Zach Daniels - CTO
• Ralf Gerteis - Commercial Strategy
• Alexander Sverdlov - Cybersecurity Strategy
• Meredith Darden - Digital Marketing Leader
• Alexey Popov - Web Development
• Michael Gubert - UI / UX Design
• Leon Rebolledo - Main Architect
• Rolf Günter - Legal Counsel
• Bobby Kaura - Business Development
• Dr. Mohamed Abdulla - Clinical Transformation
• Dr. Hasham Al-Meshhedani - Patient Involvement
• Ali Al-Sudani - Clinical Pharmacist
• Dr. Rami Radwan - Clinical Relation
• Peter Sandbach - Director of Communications
• Debra De Silva-Sun - HEOR & Analyst Appraisal
• Marko Granic - Graphic Designer

ADVICE DIGIPHARM

• Sven Möller - ICO Adviser. Swisscom Blockchain AG
• Kamal Youssefi - Corporate Advisory Blockchain. Swisscom Blockchain AG
• Waldemar Scherer - Life Sciences Blockchain Advisor. Swisscom Blockchain AG
• Sam Mantle - Technology Advisor for Life & Health Sciences. Luxoft
• Daniel Heller - PR Adviser. Partner, Farner Consulting AG
• Claudio Staub - Co-Head Startup Communications. Farner Consulting AG
• Anas Aman - Quality and Testing. IBM
• Lloyd Jefferies - CRM Advisor. KPMG
• Per-Olof Thuresson - Health Economist. Roche
• Fadi Chehadah - Health Economist. NICE UK

Digipharm uses blockchain technology on their platform to enable and promote the distribution of universally available, safe and transparent medical data infrastructure. Maintenance and utility of this platform will provide the joint protection of advanced security measures that comply with the information management protocol. Digipharm strongly believes in strengthening patients with full ownership and custody of their personal data. This is the desired level of security in today's health care industry.

For more information about Digipharm, please visit:

Website: https://www.digipharm.ch/
Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf
Telegram: https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ
Facebook: https: //www.facebook.com/digipharmteam
Twitter: https://twitter.com/DigipharmTeam

AUTOR : Damar
Proflelink :  https://bitcointalk.org/index.php?action=profile;u=1764605
ETH : 0xC020707CB64a02B77f47787C6C9Ca2Fdf127c12E